http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012123505-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21be74f3a257b485ac39f5078a1cb54c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91fe1cddc99f9255118b5a663deed0fc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-378
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37258
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
filingDate 2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_598a7e501c107921e5c50abc0cd9fb65
publicationDate 2012-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2012123505-A1
titleOfInvention Implantabale neurostimulator-initiated status notification
abstract A medical system comprises an implantable medical device having a power source, the implantable medical device configured for monitoring a quantity of the stored energy in the power source, generating a battery status signal based on the monitored quantity of stored energy, and for transcutaneously transmitting a communication initiation signal and the battery status signal. The medical system further comprises an external device configured for transcutaneously receiving the communication initial signal and the battery status signal from the rechargeable implantable medical device, changing from a relatively low energy consumption state to a relatively high energy consumption state in response to the received communication initiation signal, and for generating a user-discernible signal in response to the received status signal.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10971950-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9855436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11722007-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9343923-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113316822-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9780596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8594806-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9935498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10447083-B2
priorityDate 2010-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006122667-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300

Total number of triples: 29.